Drug Discovery

Exploring the potential of vaccines for treatment equity.

How can the NLRP3 inflammasome can be exploited to slow the decline associated with Alzheimer's disease?

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus.

Antibody drug conjugates are starting to transform cancer treatments, so let’s maintain the momentum.

Stating an intention to be ready to win in any biowarzone, the US military has commissioned Dynavax to develop a vaccine for the plague.

Setting its sights on self-amplifying RNA, AstraZeneca has signed a deal with Imperial College London spinoff VaxEquity.

Biotech companies need good patient samples, but hospitals are not always obliging...

Researchers at Trinity College Dublin explain how they are reaching into the natural environment to source new bioactives.

Analytical science has a key role to play in the development of new pharmaceutical products – from discovery, to protein analysis, to quality control.

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.